Skip to Main Content

156

Views

0

CrossRef citations to date

0

Altmetric

Original Research

Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome

Cong Shi1 Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information

,

Shengping Gong2 Cancer Radiotherapy and Chemotherapy Center, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information

,

An Wu3 Hematology Department, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information

,

Tingting Niu1 Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information

,

Ningning Wu1 Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information

,

Yi Zhang1 Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information

,

Guifang Ouyang3 Hematology Department, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

&

Qitian Mu1 Laboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo, Zhejiang, People’s Republic of ChinaView further author information